Navigation Links
Par Pharmaceutical Reports Third-Quarter 2007 Results
Date:12/20/2007

WOODCLIFF LAKE, N.J., Dec. 20 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today filed with the U.S. Securities and Exchange Commission (SEC) its Form 10-Q for the third quarter of 2007. The filing of Par's Form 10-Q for this period had been delayed due to the work involved in restating its consolidated financial statements for certain prior periods, which were filed earlier this year. As a result of today's filing, the Company is now up-to-date on all of its reporting obligations with the SEC.

Third-Quarter and Nine-Month Results

For the third quarter ended September 29, 2007, Par reported total revenues of $212.7 million and net income of $1.3 million, or $0.04 per diluted share. This is compared with reported revenues of $174.0 million and net income of $4.4 million, or $0.13 per diluted share, for the same period in 2006. For the nine months ended September 29, 2007, Par reported total revenues of $614.5 million and net income of $45.6 million, or $1.30 per diluted share. This is compared with reported revenues of $541.5 million and net income $1.7 million, or $0.05 per diluted share, for 2006.

Third-quarter 2007 reported, or GAAP, results include $16.2 million of costs related to business development activities in support of the Company's branded division, Strativa, which are discussed in more detail below. Adjusting for this item, net income for the third quarter 2007 was $11.1 million, or $0.32 per diluted share. By comparison, third-quarter 2006 results included $7.1 million of severance costs and a $1.2 million net gain relating to the sale of certain product rights. Adjusting for these items, the Company posted net income of $8.0 million, or $0.23 per diluted share for the third-qu
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... be reaping enormous income for patients whose hospital ... in their intensive care units. , In a ... American Journal of Medical Quality , the researchers ... avoidable central line-associated bloodstream infection (CLABSI) costs nearly ... similar infection-free patient. Moreover, hospitals earn nearly nine ...
(Date:5/22/2013)... Recent tragedies including the Oklahoma tornado, ... in Newtown, Connecticut all resulted in serious, and ... medical practitioners train to respond to both adult ... for Children (EMSC) Program specifically provides instruction, education ... patients. It is estimated 30 million children will ...
(Date:5/22/2013)... Space Girl Organics is excited to announce ... I Talk to Strangers Miracle Run/Walk . The 5K ... Park in Cocoa, FL. The event aims to “create miracles” ... movement. , As a sponsor, Space Girl Organics is organizing ... event. Additionally, they are providing bananas for runners and donating ...
(Date:5/22/2013)... Pamela Isom, President and CEO of ... Journal’s 2013 Women of Influence Award in recognition for ... The reception took place on Thursday, May 2 at ... is particularly humbling for the 5,000 people ICE Safety ... is to recognize the four to nine lives saved ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Homeopathic Vibes ... who cannot make it to the store during normal hours. ... , “The change is to accommodate some of our patients ... during the day time or on Saturdays,” says owner and ... are 10 a.m. to 6 p.m. Monday through Friday; weekends ...
Breaking Medicine News(10 mins):Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:Space Girl Organics to Sponsor May 25 Miracle Run/Walk 2Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2Health News:Homeopathic Vibes Now Open Late on Wednesdays 2
... According to estimates there are 85,000 Alzheimer patients in ... This spectacular increase is due to the increasing ageing ... process forms the basis of this spectacular rise in ... K.U.Leuven have discovered an important molecular link between Alzheimer,s ...
... to End the Crisis of Poor Self Image ... Challenging Cultural Ideals About Identity and Beauty, ... Eating Disorders,( http://www.remudaranch.com ), the nation,s leading and ... from eating disorders and,FINDINGbalance ( http://www.findingbalance.com ), a ...
... telemedicine is the key to transforming healthcare by making medical care more ... in response to the following problems that plague patients and practitioners in ... inefficient U.S. healthcare system:, * Doctors ... primary care physician, and nearly one-in-four have problems ...
... Switched Patients to Merck,s ... from Decision Resources, WALTHAM, Mass., April 22 ... and advisory firms for pharmaceutical and,healthcare issues, finds ... endocrinologists who consider the cardiovascular safety of,GlaxoSmithKline,s Avandia ...
... VALENCIA, Calif., April 22 On May ... Bittman, MD and internationally,renowned music therapist Christine ... Drumming facilitation training program.,This weekend training includes ... a research-based protocol using group,drumming for health ...
... GeneGo, Inc., the leading,provider of software and databases ... the Chinese University of Hong Kong,Pediatric department will ... drug targets for a large variety of diseases ... to license MetaCore, as well as,species-specific content for ...
Cached Medicine News:Health News:Ground-breaking new insight into the development of Alzheimer's disease 2Health News:Remuda Programs for Eating Disorders and FINDINGbalance Partner to End Poor Self Image 2Health News:Remuda Programs for Eating Disorders and FINDINGbalance Partner to End Poor Self Image 3Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 2Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 3Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 4Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 5Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 6Health News:Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis 2Health News:Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis 3Health News:Internationally Acclaimed Music and Medicine Program Comes to Chaska 2Health News:GeneGo's First Customer in Hong Kong; The Chinese University of Hong Kong 2
(Date:5/22/2013)...  Flagship Ventures, a leading venture capital and ... today announced the appointment of Stephane ... this role, Mr. Bancel will provide strategic counsel ... addition to working closely with companies in the ... and Chief Executive Officer of Moderna Therapeutics, a ...
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
(Date:5/22/2013)... 22, 2013  Ohr Pharmaceutical Inc. (OTCQB: OHRP), a ... for unmet medical needs, today announced the appointment of ... to its Board of Directors. Dr. Almenoff has extensive ... late stage drug development. "We are ... Dr. Irach Taraporewala, CEO of Ohr Pharmaceutical. "She offers ...
Breaking Medicine Technology:Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Inquire...
... Hamilton is precision, ergonomics, and ... hand fatigue with soft non-slip, contoured ... with smooth, light plunger spring action ... and sterilization without the need for ...
Medicine Products: